Nursing care R&D Unit, Centre for Public Health (CeFAM), Sweden.
Scand J Public Health. 2011 Jun;39(4):354-60. doi: 10.1177/1403494810396398. Epub 2011 Jan 27.
To explore the capability of the Safe Medication Assessment (SMA) tool in identifying factors highly related to unsafe medication management among elderly patients and to investigate the district nurses' (DNs) opinions of the SMA's usefulness as a tool in their daily primary healthcare practice.
Elderly patients who experience many medical conditions often use multiple drugs. As well as the combined decline in physical and cognitive functions, the elderly are at high risk for medication-related problems. It is essential to develop a screening procedure to distinguish elderly at risk of an unsafe medication management.
An explorative study. During a 3-6-month period, 25 voluntary DNs used SMA with 160 patients (consecutively chosen and meeting four specified criteria) in their daily practice. Furthermore, DNs responded to questions regarding SMA's usefulness.
The result showed that SMA had the capability to identify factors highly related to unsafe medication management among the elderly included in the study. In 64% of assessments DNs identified areas of new information and in 23% of the assessments DNs intervened. They found SMA to be satisfactory regarding its level of simplicity, relevance, completeness, intelligibility, and time for implementation.
SMA alerted the DNs to patients' attitudes about medication and empowered them in identifying elderly patients who had unsafe medication management. SMA was also perceived as a useful assessment tool by the DNs.
探索安全用药评估(SMA)工具在识别与老年患者不安全用药管理高度相关的因素方面的能力,并调查地区护士(DN)对 SMA 作为其日常初级保健实践工具的有用性的看法。
患有多种疾病的老年患者经常使用多种药物。除了身体和认知功能的综合下降外,老年人还面临着与药物相关的问题的高风险。开发一种筛选程序来区分有不安全用药管理风险的老年人至关重要。
一项探索性研究。在 3-6 个月的时间里,25 名自愿的 DN 使用 SMA 对他们日常实践中的 160 名患者(连续选择并符合四个指定标准)进行评估。此外,DN 对 SMA 的有用性回答了问题。
结果表明,SMA 能够识别研究中包括的老年患者中与不安全用药管理高度相关的因素。在 64%的评估中,DN 发现了新信息的领域,在 23%的评估中,DN 进行了干预。他们发现 SMA 在简单性、相关性、完整性、可理解性和实施时间方面令人满意。
SMA 提醒 DN 注意患者对药物的态度,并使他们能够识别出存在不安全用药管理的老年患者。SMA 也被 DN 视为一种有用的评估工具。